Coliseum Capital Management LLC Reduces Position in LHC Group (LHCG)

Coliseum Capital Management LLC reduced its position in shares of LHC Group (NASDAQ:LHCG) by 6.6% during the first quarter, Holdings Channel reports. The firm owned 730,794 shares of the health services provider’s stock after selling 51,900 shares during the period. LHC Group accounts for approximately 17.7% of Coliseum Capital Management LLC’s holdings, making the stock its 2nd largest position. Coliseum Capital Management LLC’s holdings in LHC Group were worth $39,390,000 as of its most recent filing with the SEC.

Several other large investors also recently bought and sold shares of the stock. Invictus RG bought a new stake in shares of LHC Group during the first quarter valued at about $125,000. US Bancorp DE boosted its stake in shares of LHC Group by 25.1% in the first quarter. US Bancorp DE now owns 2,683 shares of the health services provider’s stock valued at $145,000 after buying an additional 539 shares during the last quarter. Mason Street Advisors LLC boosted its stake in shares of LHC Group by 7.0% in the first quarter. Mason Street Advisors LLC now owns 3,485 shares of the health services provider’s stock valued at $188,000 after buying an additional 228 shares during the last quarter. Bayesian Capital Management LP bought a new stake in shares of LHC Group during the fourth quarter valued at about $203,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of LHC Group during the fourth quarter valued at about $208,000. Institutional investors and hedge funds own 86.67% of the company’s stock.

Institutional Ownership by Quarter for LHC Group (NASDAQ:LHCG)

Shares of LHC Group (NASDAQ LHCG) traded down 0.18% during trading on Friday, hitting $65.81. The company’s stock had a trading volume of 173,471 shares. LHC Group has a 52 week low of $32.04 and a 52 week high of $66.53. The firm’s 50 day moving average price is $60.76 and its 200-day moving average price is $51.36. The company has a market cap of $1.20 billion, a PE ratio of 30.47 and a beta of 0.79.

TRADEMARK VIOLATION WARNING: “Coliseum Capital Management LLC Reduces Position in LHC Group (LHCG)” was first posted by WKRB News and is owned by of WKRB News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of US and international copyright & trademark laws. The legal version of this piece can be accessed at https://www.wkrb13.com/markets/2228875/coliseum-capital-management-llc-reduces-position-in-lhc-group-lhcg.html.

Several analysts have recently issued reports on LHCG shares. SunTrust Banks, Inc. upgraded LHC Group from a “hold” rating to a “buy” rating and increased their price objective for the company from $50.00 to $56.00 in a research note on Friday, March 10th. Royal Bank of Canada cut LHC Group from an “outperform” rating to a “sector perform” rating and raised their price target for the company from $44.00 to $58.00 in a research note on Friday, March 10th. Craig Hallum set a $57.00 price target on LHC Group and gave the company a “buy” rating in a research note on Saturday, March 11th. Zacks Investment Research upgraded LHC Group from a “sell” rating to a “hold” rating in a research note on Tuesday, March 14th. Finally, Jefferies Group LLC restated a “buy” rating and issued a $65.00 price target (up from $56.00) on shares of LHC Group in a research note on Friday, May 5th. Eight research analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and an average target price of $64.38.

In related news, Director Coliseum Capital Management, L sold 10,215 shares of the firm’s stock in a transaction on Friday, June 9th. The shares were sold at an average price of $65.14, for a total value of $665,405.10. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, COO Donald Dwayne Stelly sold 3,181 shares of the firm’s stock in a transaction on Thursday, June 8th. The shares were sold at an average price of $64.97, for a total transaction of $206,669.57. Following the completion of the transaction, the chief operating officer now owns 114,235 shares in the company, valued at $7,421,847.95. The disclosure for this sale can be found here. Insiders sold a total of 668,389 shares of company stock worth $41,191,311 over the last quarter. 18.30% of the stock is currently owned by company insiders.

About LHC Group

LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.

Want to see what other hedge funds are holding LHCG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LHC Group (NASDAQ:LHCG).

This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2228875/coliseum-capital-management-llc-reduces-position-in-lhc-group-lhcg.html

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.